NOVARTIS AG-REG (NOT.DE) Stock Overview
FRA:NOT - CH0012005267 - Common Stock
NOT.DE Key Statistics, Chart & Performance
The current stock price of NOT.DE is 108.92 EUR. In the past month the price increased by 5.24%.
NOT.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 45.64 | 601.76B | ||
| LLY.DE | ELI LILLY & CO | 45.58 | 600.91B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.07 | 426.94B | ||
| JNJ.DE | JOHNSON & JOHNSON | 17.65 | 366.74B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 14.02 | 238.73B | ||
| 1ROG.MI | ROCHE HOLDING AG-GENUSSCHEIN | 13.21 | 224.97B | ||
| NOV.DE | NOVO NORDISK A/S-B | 14.54 | 215.73B | ||
| SNW.DE | SANOFI | 11.44 | 210.70B | ||
| SAN.PA | SANOFI | 11.43 | 210.51B | ||
| 1SAN.MI | SANOFI | 11.42 | 210.31B | ||
| 1MRKX.MI | MERCK & CO. INC. | 11.01 | 182.59B | ||
| 6MK.DE | MERCK & CO. INC. | 10.9 | 180.84B |
Related stock screener links
About NOT.DE
Company Profile
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Company Info
NOVARTIS AG-REG
Lichtstrasse 35
Basel BASEL-STADT CH
Employees: 75883
Phone: 41613241111
NOVARTIS AG-REG / NOT.DE FAQ
What is the stock price of NOVARTIS AG-REG today?
The current stock price of NOT.DE is 108.92 EUR. The price increased by 0.89% in the last trading session.
What is the ticker symbol for NOVARTIS AG-REG stock?
The exchange symbol of NOVARTIS AG-REG is NOT and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is NOT.DE stock listed?
NOT.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for NOVARTIS AG-REG stock?
31 analysts have analysed NOT.DE and the average price target is 111.85 EUR. This implies a price increase of 2.69% is expected in the next year compared to the current price of 108.92. Check the NOVARTIS AG-REG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NOVARTIS AG-REG worth?
NOVARTIS AG-REG (NOT.DE) has a market capitalization of 210.85B EUR. This makes NOT.DE a Mega Cap stock.
How many employees does NOVARTIS AG-REG have?
NOVARTIS AG-REG (NOT.DE) currently has 75883 employees.
What are the support and resistance levels for NOVARTIS AG-REG (NOT.DE) stock?
NOVARTIS AG-REG (NOT.DE) has a support level at 100.13 and a resistance level at 108.93. Check the full technical report for a detailed analysis of NOT.DE support and resistance levels.
Is NOVARTIS AG-REG (NOT.DE) expected to grow?
The Revenue of NOVARTIS AG-REG (NOT.DE) is expected to grow by 9.54% in the next year. Check the estimates tab for more information on the NOT.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NOVARTIS AG-REG (NOT.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NOT.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NOT.DE, evaluating the profitability, health, valuation and growth aspects
- NOVARTIS AG-REG (NOT.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NOVARTIS AG-REG (NOT.DE) Sales and EPS estimates to see what analysts future expectations are.
- NOVARTIS AG-REG (NOT.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NOVARTIS AG-REG (NOT.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- NOVARTIS AG-REG (NOT.DE) Stock Chart to make your own analysis
- NOVARTIS AG-REG (NOT.DE) Latest news and press-releases to stay up to date.
Does NOVARTIS AG-REG (NOT.DE) stock pay dividends?
NOVARTIS AG-REG (NOT.DE) has a dividend yield of 1.83%. The yearly dividend amount is currently 3.27. Check the full fundamental report for a detailed analysis of NOT.DE dividend history, reliability and sustainability.
When does NOVARTIS AG-REG (NOT.DE) report earnings?
NOVARTIS AG-REG (NOT.DE) will report earnings on 2025-10-28, before the market open.
What is the Price/Earnings (PE) ratio of NOVARTIS AG-REG (NOT.DE)?
The PE ratio for NOVARTIS AG-REG (NOT.DE) is 14.45. This is based on the reported non-GAAP earnings per share of 7.54 and the current share price of 108.92 EUR. Check the full fundamental report for a full analysis of the valuation metrics for NOT.DE.
NOT.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to NOT.DE.
NOT.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to NOT.DE. Both the health and profitability get an excellent rating, making NOT.DE a very profitable company, without any liquidiy or solvency issues.
NOT.DE Financial Highlights
Over the last trailing twelve months NOT.DE reported a non-GAAP Earnings per Share(EPS) of 7.54. The EPS increased by 22.58% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.9% | ||
| ROA | 13.08% | ||
| ROE | 32.52% | ||
| Debt/Equity | 0.57 |
NOT.DE Forecast & Estimates
31 analysts have analysed NOT.DE and the average price target is 111.85 EUR. This implies a price increase of 2.69% is expected in the next year compared to the current price of 108.92.
For the next year, analysts expect an EPS growth of 16.29% and a revenue growth 9.54% for NOT.DE